VVOS – vivos therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Vivos Therapeutics (VVOS) had its price target lowered by Ascendiant Capital Markets from $5.50 to $3.00. They now have a "buy" rating on the stock.
Vivos Therapeutics (VVOS) had its "sell (e+)" rating reaffirmed by Weiss Ratings.
Vivos Therapeutics (VVOS) had its price target lowered by HC Wainwright from $7.00 to $2.50. They now have a "buy" rating on the stock.
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... [Yahoo! Finance]
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call [Yahoo! Finance]
Form 8-K Vivos Therapeutics, Inc. For: Apr 22
Form 8-K Vivos Therapeutics, Inc. For: Apr 15
Form 10-K Vivos Therapeutics, Inc. For: Dec 31
Form 3 Vivos Therapeutics, Inc. For: Mar 31 Filed by: V-Co Investors 3 LLC
Form 8-K Vivos Therapeutics, Inc. For: Apr 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.